Commitments and contingencies (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Jul. 11, 2023 |
Aug. 27, 2021 |
Oct. 31, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Jun. 30, 2020 |
Jun. 30, 2025 |
|
| Law suit filing date | May 28, 2019 | ||||||
| G Farma Settlors [Member] | |||||||
| Litigation settlement amount awarded from other party | $ 2,539,597 | $ 2,539,597 | |||||
| Litigation settlement default amount | 2,494,450 | ||||||
| Interest receivable | 40,219 | $ 500,962 | |||||
| Litigation settlement costs | 1,643 | ||||||
| Attorneys fee | $ 3,285 | ||||||
| Debt instrument, interest rate, effective percentage | 10.00% | ||||||
| Settlement Agreement and Mutual Release [Member] | G Farma Settlors [Member] | |||||||
| Liability for unpaid claims description | The Settlement Agreement requires the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest is paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25%, commencing February 25, 2021, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%. In the event that the G Farma Settlors fail to make any monthly payment and have not cured such default within 10 days of notice from the Company, the parties have stipulated that an additional $2,000,000 will be immediately added to the amount payable by the G Farma Settlors. | ||||||
| Liability for unpaid claims and claims adjustment expense, net | $ 500,000 | $ 500,000 | $ 500,000 | $ 500,000 | |||
| Liability for unpaid claims | $ 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | |||
| Remaining amount | 494,450 | 494,450 | 494,450 | ||||
| Liability for accrued unpaid interest | $ 2,000,000 | $ 2,000,000 | $ 2,000,000 | ||||
| G FarmaLabs Limited [Member] | |||||||
| Sale leaseback transaction, net book value | $ 622,670 | ||||||
| Loss contingency receivable, proceeds | $ 249,481 | ||||||